CXCL10 and skin reaction: IFNβ enhances the expression of CD80, SCYB10 (IP-10) and SCYA2 (MCP1) in situ at sites of injection, leading to chemotaxis of lymphocytes and monocytes in the lesions of skin reaction [47-49].